Should chemoradiotherapy be used in node-negative esophageal or gastric adenocarcinoma?

Naveenraj L. Solomon; Leonidas G. Koniaris

doi:10.1245/s10434-010-1014-3

Should chemoradiotherapy be used in node-negative esophageal or gastric adenocarcinoma?

Naveenraj L. Solomon, Leonidas G. Koniaris

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1717
Number of pages	1
Journal	Annals of Surgical Oncology
Volume	17
Issue number	6
DOIs	https://doi.org/10.1245/s10434-010-1014-3
State	Published - Jun 2010

ASJC Scopus Subject Areas

Surgery
Oncology

Access to Document

10.1245/s10434-010-1014-3

OpenUrl availability

Full text

Cite this

@article{79997c975e524bd8a383fa7c6e340947,

title = "Should chemoradiotherapy be used in node-negative esophageal or gastric adenocarcinoma?",

author = "Solomon, {Naveenraj L.} and Koniaris, {Leonidas G.}",

note = "We agree with Drs. Hotenrott and Ziogas that the role and timing of chemotherapy and radiation for patients with advanced disease in the esophagus and stomach needs further clarification. 1 Our retrospective study attempted to answer this question by analyzing 3378 patients treated in the state of Florida between 1998 and 2002.",

year = "2010",

month = jun,

doi = "10.1245/s10434-010-1014-3",

language = "English",

volume = "17",

pages = "1717",

journal = "Annals of Surgical Oncology",